Novo Nordisk partners with GoodRx for 499 monthly Ozempic Wegovy GDRXNASDAQ Seeking Alpha

Palantir Technologies (NASDAQ:PLTR) has shed $73 billion in market value over a six-session slide, offering a rare boost to short sellers who’ve struggled against one of Wall Street’s top performers…

Palantir (PLTR) Q2 earnings preview: options imply a 9.3% post-earnings move as calls dominate puts.

Jamie Dimon’s JPMorgan shareholder letter warns on geopolitics, oil shocks, and private credit risks—plus $1.5T U.S. security plan.